Market Research Industry Today

US Dominates the Veterinary Biomarkers Market with Largest Share: Forecast to 2031

The veterinary biomarkers market is witnessing steady growth driven by rising demand for advanced animal diagnostics, increasing pet ownership, and growing awareness of animal health. Biomarkers play a vital role in early disease detection, enabling accurate diagnosis and improved treatment outcomes across both companion animals and livestock.
Published 07 April 2026

The veterinary biomarkers market is experiencing steady growth due to the increasing focus on animal health monitoring, early disease detection, and advancements in diagnostic technologies. Biomarkers are biological indicators used to identify disease conditions in animals, playing a critical role in improving veterinary diagnostics and treatment outcomes. The market is gaining traction across both companion animals and livestock segments, driven by rising pet ownership and the need for enhanced productivity in animal farming.

The Veterinary Biomarkers Market is expected to register a CAGR of 8.9% from 2025 to 2031. This growth is supported by expanding applications in clinical diagnostics and research, along with increasing investments in veterinary healthcare infrastructure. The market is also benefiting from innovations such as molecular diagnostics and point-of-care testing, which improve accuracy and efficiency in disease detection.

Veterinary Biomarkers Market Overview

The Veterinary Biomarkers Market Analysis highlights a rapidly evolving industry characterized by technological advancements and growing demand for precise diagnostic tools. Biomarkers are increasingly used to detect infectious diseases, cancer, cardiovascular disorders, and renal conditions in animals. The integration of advanced diagnostic platforms enables veterinarians to make faster and more accurate clinical decisions.

Market segmentation reveals strong demand across product categories such as kits and reagents, along with biomarker readers. Kits and reagents dominate the market due to their widespread use in routine diagnostics and research applications. Additionally, companion animals represent a significant share of the market, as pet owners are increasingly willing to invest in preventive healthcare solutions.

From an application perspective, clinical diagnostics remains the leading segment, driven by the rising number of veterinary visits and diagnostic procedures. Research applications are also expanding, particularly in the development of novel biomarkers and personalized veterinary medicine.

What are the Key Drivers of the Veterinary Biomarkers Market?

Several factors are contributing to the growth of the veterinary biomarkers market:

  • Rising Demand for Animal Health Monitoring: Increased awareness about animal health and welfare is driving the adoption of biomarker-based diagnostics. Pet owners and livestock producers are seeking early detection methods to prevent disease progression.
  • Advancements in Diagnostic Technologies: Innovations such as next-generation sequencing, molecular diagnostics, and point-of-care testing are enhancing the efficiency and accuracy of veterinary diagnostics.
  • Growing Prevalence of Animal Diseases: The rising incidence of infectious and chronic diseases in animals is boosting demand for advanced diagnostic tools.
  • Regulatory Support and Funding: Government initiatives and funding for animal health research are further accelerating market growth.

These drivers collectively support the expansion of biomarker applications across veterinary clinics, hospitals, and research institutes.

Download PDF Sample: https://www.theinsightpartners.com/sample/TIPRE00040895

Which Region Dominates the Veterinary Biomarkers Market?

Geographically, North America holds the largest share of the veterinary biomarkers market, driven by well-established veterinary healthcare infrastructure, high pet ownership rates, and strong presence of key market players.

Europe follows closely, supported by increasing investments in animal health and stringent regulations related to animal welfare. Meanwhile, the Asia-Pacific region is expected to witness the highest growth rate during the forecast period due to rising awareness, expanding veterinary services, and growing livestock population.

Emerging economies such as China and India are becoming significant contributors to market growth, fueled by increased spending on animal healthcare and the adoption of advanced diagnostic technologies.

Competitive Landscape and Key Players

The veterinary biomarkers market is highly competitive, with several global and regional players focusing on innovation and strategic collaborations. Leading companies are investing in research and development to introduce advanced biomarker-based diagnostic solutions.

Key players operating in the market include:

  • Zoetis
  • Virbac
  • Life Diagnostics
  • ACUVET BIOTECH
  • Merck & Co., Inc.
  • IDEXX Laboratories, Inc.
  • MI:RNA Diagnostics Ltd.
  • Mercodia AB
  • Antech Diagnostics, Inc.
  • Avacta Animal Health Limited

These companies are actively engaged in product launches, partnerships, and acquisitions to strengthen their market position and expand their global footprint.

Market Segmentation Insights

The veterinary biomarkers market is segmented based on animal type, product type, disease type, and application.

  • By Animal Type: Companion animals and livestock
  • By Product Type: Readers, kits, and reagents
  • By Disease Type: Infectious diseases, cardiovascular disorders, cancer, and renal diseases
  • By Application: Clinical diagnostics and research

Among these, the companion animal segment holds a significant share due to increased pet adoption and growing expenditure on pet healthcare. Infectious diseases account for a major portion of the market, as early detection is crucial to prevent disease spread and ensure animal safety.

Future Outlook

The future of the veterinary biomarkers market looks promising, with continuous advancements in diagnostic technologies and increasing adoption of precision veterinary medicine. The integration of artificial intelligence and data analytics is expected to enhance biomarker discovery and improve diagnostic accuracy.

Furthermore, the expansion of veterinary healthcare services in emerging markets and the rising demand for point-of-care testing solutions will create new growth opportunities. The market is also likely to benefit from increased collaboration between research institutions and industry players to develop innovative biomarker solutions.

As the focus on animal health and food safety continues to grow, the veterinary biomarkers market is poised for sustained expansion through 2031.

Related Reports

Veterinary Molecular Diagnostics Market Growth, Key Players, and Forecast by 2031

Aquatic Veterinary Market Size, Trends & Forecast to 2031

About Us

The Insight Partners is a leading provider of actionable market intelligence and consulting services across various industries. Our research reports combine advanced analytics, expert insights, and reliable data to help organizations identify new opportunities, optimize strategies, and achieve sustainable growth. We specialize in delivering in-depth market studies covering healthcare, technology, manufacturing, and emerging sectors.

Contact Us

If you have any queries regarding this report or would like additional information, please contact us:

Email: sales@theinsightpartners.com

Other Industry News

Ready to start publishing

Sign Up today!